• News
  • Medical

Sanitas gets FDA approval for mobile patient monitor

Sanitas Inc., a San Diego company developing mobile and Web solutions for outpatients with chronic conditions, has received approval from the U.S. Food and Drug Administration on a 510(K) class II medical device for Wellaho, its proprietary mobile and web platform.

Wellaho is a physician-directed, Web-based and mobile platform that allows providers to supervise and monitor patients between office visits in a secure, HIPAA compliant environment. It enables patients to access their medical information, monitor their condition, stream relevant educational materials and connect securely to their doctors and health care team.

Wellaho's personalized outpatient management system is currently deployed in a number of clinical studies at UC San Diego Health Services.


Bill Walton promotes NuVasive's spinal surgery around country

Scripps taking over San Diego Hospice & Palliative

Santarus launches colitis drug

User Response
0 UserComments